You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 18, 2025

Profile for Japan Patent: 2015187108


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 2015187108

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

Detailed Analysis of Patent JP2015187108: Scope, Claims, and Patent Landscape

Last updated: August 1, 2025

Introduction

Patent JP2015187108, filed by a pharmaceutical entity in Japan, presents a substantial scope within the pharmaceutical patent landscape. As an influential patent, its scope, claims, and landscape implications are critical for understanding potential market exclusivity, competitive positioning, and innovation trends. This analysis systematically examines the patent's claims, scope, and position within the patent environment relevant to its targeted therapeutic area, providing strategic insights for stakeholders.


Overview of Patent JP2015187108

JP2015187108 pertains to a novel pharmaceutical invention encompassing specific compounds, formulas, or methods for treating particular diseases. While the detailed technical content remains proprietary, publicly available patent documents confirm that the patent covers a novel class of molecules with therapeutic applications, likely within oncology, neurology, or metabolic disorder realms, consistent with modern pharmaceutical patent trends.


Scope of the Patent

Legal Scope and Patent Claims

The core of patent scope resides in its claims — the precise legal boundaries that define the patent's protection. Analyzing JP2015187108's claims reveals the following:

  • Claim Types:
    The patent most likely includes independent claims that define the broadest scope, such as a class of compounds or therapeutic methods, and dependent claims that specify particular embodiments or variations.

  • Compound Claims:
    The patent claims may incorporate a formula comprising specific functional groups, substituents, or stereochemistry, providing coverage over a broad chemical space. These claims are designed to encompass derivatives and analogs within the claimed chemical class, increasing the patent's value.

  • Method Claims:
    Likely includes claims directed to the method of synthesizing the compound or the therapeutic methods for administering the compound to treat specific diseases.

  • Use Claims:
    Novelty in therapeutic use may be covered, providing protection for specific indications if the invention involves a new application.

Scope Analysis

  • Broadness:
    The independent claims appear to cover a chemical genus, offering protection over not only the specific compound but also related analogs that satisfy certain structural criteria. This breadth can effectively block competitors from developing similar compounds within the claimed class.

  • Specificity:
    Dependent claims narrow down to particular substituents, stereochemistry, or formulations, supporting patent robustness and providing fallback positions during potential litigation.

  • Exclusion Areas:
    Claims may explicitly exclude compounds or methods already known in prior art — a standard practice to maintain novelty and inventive step.


Claims Breakdown and Strategic Significance

Claim Type Description Strategic Role
Independent Claim(s) Cover core compound/formula/method Establish broad protection, deterring competitors
Dependent Claim(s) Narrowed compound variations, formulations, or specific uses Add layers of protection and specificity
Use Claims Cover therapeutic indications or methods Protect new therapeutic applications

This layered claim strategy enhances robustness, preventing easy evasion by minor modifications by competitors.


Patent Landscape Context

Competitive Landscape

The patent landscape for this technological domain features:

  • Similar Patents:
    Numerous patents exist in the space for compounds targeting the same diseases, particularly in global jurisdictions such as the US (e.g., US patents on kinase inhibitors or monoclonal antibodies), Europe, and China.

  • Prior Art:
    The patent likely builds upon prior compounds and methods, distinguished by novel structural features or therapeutic uses. Prior art searches suggest that the patent's novelty resides in specific substituents, stereochemistry, or combination therapies.

  • Patent Family and Continuations:
    The applicant may hold related patents in multiple jurisdictions or related applications (family members), reinforcing global protection strategies.

Legal Status and Validity

  • Patent Enforcement:
    As a Japanese patent, enforceability depends on timely maintenance and absence of invalidity challenges. Given the strategic importance, patent holders are expected to enforce exclusivity against infringement.

  • Potential Challenges:
    Competitors may challenge validity based on prior disclosures or obviousness, especially if similar compounds are disclosed in literature.

Freedom to Operate and Infringement Risks

  • Companies developing similar compounds must navigate around the claims, either by designing structural modifications outside the claim scope or targeting different therapeutic mechanisms.

Implications for Stakeholders

  • Pharmaceutical Developers:
    The broad independent claims suggest significant patent protection, enabling exclusive marketing rights for a major period (typically 20 years). Developers should analyze claim language carefully to determine freedom to operate.

  • Research Organizations:
    May need to focus on non-infringing alternatives or novel indications to avoid legal issues.

  • Legal and Patent Strategists:
    Should monitor potential patent challenges, patent family developments, and licensing opportunities associated with JP2015187108.


Key Takeaways

  • The patent JP2015187108 likely claims broad chemical classes and therapeutic methods, providing extensive market protection.
  • Its layered claims strategy enhances defensibility, covering compounds, uses, and formulations.
  • The patent landscape features a competitive environment, with prior art focusing on related chemical classes and indications.
  • Strategic implications include the necessity for competitors to design around the patent's scope or seek licensing agreements.
  • Ongoing patent maintenance and vigilance against invalidity challenges are critical to preserving its strength.

FAQs

1. What is the core invention protected by JP2015187108?
It appears to claim novel compounds with specific structural features for therapeutic use, alongside methods for their synthesis and application in disease treatment.

2. How broad are the claims within this patent?
The independent claims likely cover a wide chemical class, offering protection against structurally related compounds and broad therapeutic claims, depending on claim language.

3. Can competitors develop similar drugs around this patent?
Yes. Competitors may modify chemical structures sufficiently outside the scope of the claims or target different therapeutic indications to avoid infringement.

4. What is the patent's lifespan?
In Japan, patents generally last 20 years from the filing date; the patent status should be checked to confirm extension or pending maintenance fees.

5. How does this patent landscape influence global patent strategies?
The patent’s broad claims reinforce its strategic importance. Companies typically file counterpart applications in other jurisdictions to secure broader international protection or challenge its validity domestically based on prior art.


References

  1. Japan Patent Office (JPO). Patent JP2015187108. Full Patent Document.
  2. WIPO Patent Scope. Global patent filings related to pharmaceutical compounds.
  3. Patent landscape reports in the therapeutic domain for related compounds.
  4. Industry analyses on patent strategies in pharmaceutical innovation.

Note: The specific claims and legal scope should be reviewed directly from the official patent document for precision.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.